Posttreatment plasma transforming growth factor beta 1 level predicts for late morbidity in parients with advanced head and neck cancer
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61988987%3A17110%2F05%3AA0900HLJ" target="_blank" >RIV/61988987:17110/05:A0900HLJ - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Posttreatment plasma transforming growth factor beta 1 level predicts for late morbidity in parients with advanced head and neck cancer
Original language description
Methods and materials Between 2001-2002, 36 patients with advanced inoperable squamous head and neck cancer treated with radiotherapy with or without simultaneous chemotherapy were evaluated for their plasma TGF-b1 levels prior to the treatment, in the middle of the radiotherapy course and at the end of the treatment. The patients were assessed for treatment response and late morbidity. Results There were 29 eligible patients (pts), the rest being lost of follow-up. Of these 29 pts, 18 achieved completeresponse, 8 partial response and three pts progressed primarily. After a median follow-up of 16 months (range 3-28), we recorded 16 cases of grade > 1 late morbidity. We found that posttreatment elevated plasma TGF-b1 level predicts late morbidity grade>1 (p=0,05 see Graph 1) rather than pretreatment level (p=0,062). Conclusion Posttreatment plasma TGF-beta 1 level can predict late morbidity grade >1 in advanced head and neck cancer treated with radio(chemo)therapy.
Czech name
Poléčebná hodnota TGF-beta1 predikuje vyšší postradiační morbiditu u pacientů s pokročilými ORL malignitami
Czech description
Publikace hodnotí prediktivní význam TGF-beta1 u pacientů ozařovaných pro pokročilé nádory hlavy a krku. Výsledkem publikace je, že vysoká poléčebná hodnota TGF-beta1 predikuje vyšší pozdní postradiační morbiditu.
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
—
Continuities
S - Specificky vyzkum na vysokych skolach
Others
Publication year
2005
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
NEOPLASMA
ISSN
0028-2685
e-ISSN
—
Volume of the periodical
52
Issue of the periodical within the volume
1
Country of publishing house
SK - SLOVAKIA
Number of pages
5
Pages from-to
—
UT code for WoS article
000232222100007
EID of the result in the Scopus database
—